Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanjay Goel

Showing results (81-90 of 182) with videos related to

Pageof 19
Sort By:
Investigational New Drugs|June 11, 2003
A phase II study of rebeccamycin analog NSC 655649 in patients with metastatic colorectal cancerSanjay Goel, Scott Wadler, Anthony Hoffman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2003
A safety study of a mixed-backbone oligonucleotide (GEM231) targeting the type I regulatory subunit alpha of protein kinase A using a continuous infusion schedule in patients with refractory solid tumorsSanjay Goel, Kavita Desai, Anca Bulgaru, et al.
Investigational New Drugs|March 6, 2024
Impact of carbamazepine on SMARCA4 (BRG1) expression in colorectal cancer: modulation by KRAS mutation statusAaron Shaykevich, Danbee Chae, Isaac Silverman, et al.
Oncotarget|May 7, 2014
Oncolytic reovirus preferentially induces apoptosis in KRAS mutant colorectal cancer cells, and synergizes with irinotecanRadhashree Maitra, Raviraja Seetharam, Lydia Tesfa, et al.
Pharmacotherapy|May 31, 2014
A phase I study in patients with solid or hematologic malignancies of the dose proportionality of subcutaneous Azacitidine and its pharmacokinetics in patients with severe renal impairmentEric Laille, Sanjay Goel, Alain C Mita, et al.
Journal of Cardiothoracic and Vascular Anesthesia|December 6, 2005
Aspiration of a cystic mediastinal mass as a method of relieving airway compression before definitive surgeryDeepak K Tempe, Vishnu Datt, Sanjula Virmani, et al.
Cancer Chemotherapy and Pharmacology|June 14, 2019
A phase 1b, multicenter, open-label, dose-finding study of eribulin in combination with carboplatin in advanced solid tumors and non-small cell lung cancerSanjay Goel, Umang Swami, Kirushna Kumar, et al.
Clinical Pharmacology in Drug Development|June 4, 2020
Phase 1 Study to Evaluate the Effect of the Investigational Anticancer Agent Sapanisertib on the QTc Interval in Patients With Advanced Solid TumorsChirag Patel, Sanjay Goel, Manish R Patel, et al.
Cancer Research Communications|May 8, 2024
Molecular Landscape and Clinical Implication of CCNE1-amplified Esophagogastric CancerNaryan Rustgi, Sharon Wu, Timothy Samec, et al.
Chemosphere|September 7, 2010
CYP 1A1 polymorphism and organochlorine pesticides levels in the etiology of prostate cancerVivek Kumar, Chandra Shekhar Yadav, Satyender Singh, et al.
Pageof 19

Showing results (81-90 of 182) with videos related to

Sort By:
Pageof 19
Investigational New Drugs|June 11, 2003
A phase II study of rebeccamycin analog NSC 655649 in patients with metastatic colorectal cancerSanjay Goel, Scott Wadler, Anthony Hoffman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2003
A safety study of a mixed-backbone oligonucleotide (GEM231) targeting the type I regulatory subunit alpha of protein kinase A using a continuous infusion schedule in patients with refractory solid tumorsSanjay Goel, Kavita Desai, Anca Bulgaru, et al.
Investigational New Drugs|March 6, 2024
Impact of carbamazepine on SMARCA4 (BRG1) expression in colorectal cancer: modulation by KRAS mutation statusAaron Shaykevich, Danbee Chae, Isaac Silverman, et al.
Oncotarget|May 7, 2014
Oncolytic reovirus preferentially induces apoptosis in KRAS mutant colorectal cancer cells, and synergizes with irinotecanRadhashree Maitra, Raviraja Seetharam, Lydia Tesfa, et al.
Pharmacotherapy|May 31, 2014
A phase I study in patients with solid or hematologic malignancies of the dose proportionality of subcutaneous Azacitidine and its pharmacokinetics in patients with severe renal impairmentEric Laille, Sanjay Goel, Alain C Mita, et al.
Journal of Cardiothoracic and Vascular Anesthesia|December 6, 2005
Aspiration of a cystic mediastinal mass as a method of relieving airway compression before definitive surgeryDeepak K Tempe, Vishnu Datt, Sanjula Virmani, et al.
Cancer Chemotherapy and Pharmacology|June 14, 2019
A phase 1b, multicenter, open-label, dose-finding study of eribulin in combination with carboplatin in advanced solid tumors and non-small cell lung cancerSanjay Goel, Umang Swami, Kirushna Kumar, et al.
Clinical Pharmacology in Drug Development|June 4, 2020
Phase 1 Study to Evaluate the Effect of the Investigational Anticancer Agent Sapanisertib on the QTc Interval in Patients With Advanced Solid TumorsChirag Patel, Sanjay Goel, Manish R Patel, et al.
Cancer Research Communications|May 8, 2024
Molecular Landscape and Clinical Implication of CCNE1-amplified Esophagogastric CancerNaryan Rustgi, Sharon Wu, Timothy Samec, et al.
Chemosphere|September 7, 2010
CYP 1A1 polymorphism and organochlorine pesticides levels in the etiology of prostate cancerVivek Kumar, Chandra Shekhar Yadav, Satyender Singh, et al.
Pageof 19